What Is Mepilex Dressing? Uses, Types, and Benefits

Mepilex is a family of soft silicone foam wound dressings made by Mölnlycke Health Care, designed to absorb wound fluid while minimizing pain and tissue damage during dressing changes. The dressings use a proprietary adhesive layer called Safetac that sticks gently to intact skin surrounding a wound but does not adhere to the moist wound bed itself. This distinction matters more than it might sound: traditional adhesive dressings can rip away new tissue every time they are removed, which slows healing and causes significant pain. Mepilex dressings show up across a wide range of clinical settings, from post-surgical incisions and chronic leg ulcers to radiation skin reactions and fragile skin in elderly patients.

How the Safetac Adhesive Layer Works

The defining feature of Mepilex dressings is the Safetac soft silicone contact layer. Unlike acrylic or hydrocolloid adhesives that bond aggressively to skin and wound tissue alike, the silicone layer seals around the wound edges to keep fluid from leaking out while leaving the wound bed itself largely undisturbed. When it is time to change the dressing, you can peel it away without the tearing sensation that comes with conventional adhesives. In a case study of patients undergoing radiation therapy, patients reported that the dressing could be lifted and repositioned without losing its ability to stick, and that it had a soothing or cooling effect on the skin.¹

This “seal but don’t stick” approach has two practical consequences. First, it reduces maceration, the soggy white deterioration of skin that happens when wound fluid sits against intact tissue for too long. A randomized crossover trial comparing silicone foam dressings with standard foam found lower pain at removal and less maceration around the wound edges in the silicone group.² Second, because the dressing does not tear away healing tissue, clinicians can inspect the wound and reapply the same dressing if it still has absorptive capacity, which cuts down on waste and the total number of dressing changes a patient goes through.

Types of Mepilex Dressings

Mepilex is not a single product but a line of dressings tailored to different wound types, body locations, and levels of fluid output. The core technology stays the same, but the layers surrounding it change.

• Mepilex (standard): A basic absorbent foam with the Safetac contact layer. Used for moderately draining wounds like venous leg ulcers and partial-thickness burns. It requires a secondary fixation layer such as tape or a bandage to hold it in place.
• Mepilex Lite: A thinner version designed for low-to-moderately draining wounds and for use over fragile or sensitive skin, including areas undergoing radiation therapy. Its lower profile makes it comfortable under clothing or compression garments.
• Mepilex Border: An all-in-one dressing with an integrated adhesive border, so no secondary tape is needed. The border version is popular for post-surgical wounds and pressure injury prevention because it stays put during movement and rehabilitation. Shaped variants like Mepilex Border Sacrum and Mepilex Border Heel are contoured for high-risk pressure sites.
• Mepilex Ag: A silver-impregnated version that adds antimicrobial action. Lab tests show rapid and sustained activity against a range of wound pathogens, including the ability to reduce established biofilm cultures and prevent new biofilm formation.³ This version is used when wounds show signs of local infection or high bacterial burden.
• Mepilex Transfer: A thin silicone contact layer without the thick foam pad, designed to transfer fluid away from the wound into a secondary absorbent layer placed on top. It is useful for wounds that need frequent inspection or topical treatments applied directly to the wound bed.

The choice among these variants usually comes down to how much fluid the wound produces, whether infection is a concern, where on the body the wound sits, and whether the patient can tolerate a secondary fixation product. Clinicians frequently switch between variants as a wound progresses through different healing stages.

Post-Surgical Wound Care

One of the fastest-growing uses for Mepilex dressings is covering incisions after surgery, particularly after hip and knee replacements. A randomized trial comparing Mepilex Border Post-Op with another advanced surgical dressing found that the Mepilex version was comparable or better across every parameter tested. It was easier to apply and remove, handled blood more effectively, left fewer dressing residuals on the skin, and scored higher on patient satisfaction during rehabilitation.⁴

A separate randomized trial in orthopedic surgery compared Mepilex Border Post-Op against traditional gauze-based dressings. Pain scores during dressing changes on day three were roughly half those of the gauze group, and the gap persisted through the two-week follow-up period.⁵ That pain difference matters because post-surgical dressing changes are among the moments patients dread most during recovery, and high pain can interfere with the early mobilization that surgeons want after joint replacements.

Chronic Wound Management

Chronic wounds that refuse to close on a normal timeline represent a major share of Mepilex use. These include venous leg ulcers, diabetic foot ulcers, and pressure injuries. The evidence across these wound types is generally positive, though the picture varies.

For venous leg ulcers, a large randomized trial comparing Mepilex with another well-known foam dressing found that roughly two-thirds of patients healed completely with Mepilex over the study period. The healing rates were slightly higher than the comparator group, though the difference did not reach statistical significance. Pain improved with both dressings.⁶ The honest read of that trial is that Mepilex performed well but was not dramatically better than another modern foam, which makes sense given that both dressings share the same basic wound-healing approach of maintaining a moist environment.

For diabetic foot ulcers, a pilot study found that wounds treated with Mepilex Lite healed in a median of about 50 days compared with roughly 66 days in the control group, a statistically significant improvement. The Mepilex group also showed significantly greater wound area reduction over the treatment period.⁷ Diabetic foot wounds are notoriously slow to heal and prone to infection, so a two-week improvement in median healing time is clinically meaningful even if the study was small.

The silver-impregnated Mepilex Ag version has been tried on infected diabetic foot ulcers specifically. Case reports suggest some possible clinical benefit in controlling infection, though the evidence base for that particular application remains thin.⁸ Clinicians sometimes use the silver version as part of a broader infection management strategy rather than as a standalone treatment.

Preventing Pressure Injuries

An application that has gained considerable traction in recent years is using Mepilex Border dressings preventively, placed over bony prominences before pressure injuries have a chance to develop. This is different from treating an existing wound; the idea is that the foam redistributes pressure and shear forces over the sacrum, heels, and other vulnerable spots in immobile patients.

A randomized controlled trial in high-risk nursing home residents found that those who received Mepilex Border Sacrum and Mepilex Heel dressings developed far fewer pressure injuries than the control group: 3 versus 16. That translates to about an 80 percent relative risk reduction. For every 12 patients treated, one pressure injury was prevented.⁹ Given how devastating pressure injuries can be for elderly or hospitalized patients, and how expensive they are to treat once established, preventive dressing has become a standard recommendation in many hospital protocols, particularly for intensive care units and long-term care facilities.

Radiation Skin Reactions

Patients receiving radiation therapy for cancer frequently develop painful skin redness and breakdown in the treatment field. Mepilex Lite has been studied as a way to manage these reactions, and the results are encouraging. A controlled clinical trial found that the dressings significantly reduced the severity of radiation-induced skin redness compared with standard aqueous cream. The dressings also caused only a negligible increase in surface dose, meaning they are safe to wear during treatment sessions without meaningfully changing the radiation dose to the skin.¹⁰

In patients receiving radiation for nasopharyngeal cancer, a separate controlled trial showed that radiation dermatitis healed in a median of 16 days in the Mepilex Lite group versus 23 days in the control group. The dressings also significantly improved patients’ sleep quality, likely because the cooling and protective effect of the dressing reduced nighttime skin irritation.¹¹ This sleep benefit is easy to overlook in a clinical context, but it matters considerably to patients who are already dealing with the exhaustion of cancer treatment.

Skin Graft Donor Sites

When surgeons harvest a split-thickness skin graft from a healthy area of the body to cover a wound elsewhere, the donor site itself becomes a new wound that needs care. This is an area where the evidence for Mepilex-type dressings is particularly strong. A large comparative study found that skin graft donor sites dressed with Mepilex Ag had an infection rate of about 1 percent, compared with over 11 percent for sites dressed with traditional petroleum-based gauze. Patients using the gauze had roughly 10 times the odds of developing a donor site infection.¹² The authors of that study argued that moist foam dressings should be the standard of care for graft donor sites, a position that reflects a broader shift away from older “let it dry out” approaches to wound management.

Another randomized trial evaluated Mepilex and Mepilex Border alongside other modern dressings for graft donor sites, assessing healing time, pain severity and duration, frequency of dressing changes, re-epithelialization, and complications.¹³ Donor sites are especially painful because they essentially create a large, raw abrasion, so the gentle removal properties of silicone foam dressings are a meaningful comfort advantage.

Skin Tears in Older Adults

Aging skin becomes thin and fragile, and even minor bumps or shearing forces can cause skin tears, particularly in long-term care residents. These wounds look minor but can be surprisingly slow to heal and prone to complications. A randomized trial in two Canadian long-term care facilities compared silicone dressings (including both silicone contact layers and silicone foams) against non-adhesive dressings for treating skin tears. The results were striking: about 97 percent of skin tears in the silicone group healed within three weeks, compared with roughly 34 percent in the control group. Healing time was cut in half, from a median of 22 days down to 11 days.¹⁴

A pilot study comparing adhesive silicone foam dressings against meshed silicone interface dressings for hospital-acquired skin tears found that the adhesive foam group had higher complete healing rates at three weeks: 86 percent versus 59 percent per protocol.¹⁵ The integrated adhesive border probably helps by keeping the skin flap in contact with the wound bed without the additional step of taping, which itself can damage fragile skin.

Foam Versus Hydrocolloid Dressings

People sometimes encounter hydrocolloid dressings at the pharmacy and wonder how they compare. Hydrocolloids are the rubbery, opaque patches that form a gel when they absorb fluid. A review of the published literature comparing foams and hydrocolloids found that healing rates between the two types were generally similar, with only one study out of several finding a statistically significant difference, and that difference favored foam. Where foams consistently came out ahead was in ease of use: they were significantly easier to apply and remove in the majority of studies reviewed. Hydrocolloid adhesives also showed a tendency to damage both the wound bed and surrounding skin upon removal.¹⁶

This finding aligns with the broader philosophy behind Mepilex and silicone foam dressings in general: the difference between dressing types often shows up not in how fast the wound closes but in how much discomfort and skin damage the dressing itself causes along the way. For wounds that will heal on a roughly similar timeline regardless of dressing choice, reducing pain and secondary skin injury during the healing process is a genuine advantage rather than a consolation prize.

Fragile-Skin Conditions and Rare Diseases

Some of the most compelling use cases for gentle silicone dressings involve patients whose skin is exceptionally vulnerable. People with epidermolysis bullosa, a group of genetic conditions that cause the skin to blister and tear with minimal friction, face a constant challenge: their wounds need covering, but conventional dressings can cause new blisters when removed. Rigorous trial data in this population is limited because of the rarity and variability of the condition, but there is clinical consensus that advanced dressings with gentle adhesive technology help promote healing and reduce pain compared with traditional wound care approaches.

Neonatal intensive care units face a similar dilemma. Premature infants have paper-thin skin, and medical adhesives used to secure IV lines, monitors, and other equipment routinely cause skin breakdown. Silicone-based products have become a preferred option in these settings because they hold devices in place without the aggressive adhesion that tears neonatal skin. While the Mepilex line is primarily designed for wound management rather than device fixation, the same Safetac technology appears in related Mölnlycke products used for this purpose.

Practical Considerations When Using Mepilex Dressings

If you or someone you are caring for has been prescribed a Mepilex dressing, a few practical points are worth knowing. The dressings work best when the surrounding skin is clean and dry before application; moisture or residual cream under the adhesive border will weaken the seal. Most variants can be left in place for several days, depending on how much fluid the wound produces. The dressing should be changed when it becomes saturated, when it starts to lift at the edges, or at intervals specified by the treating clinician.

One thing that catches people off guard is cost. Mepilex dressings are considerably more expensive per unit than basic gauze or simple adhesive bandages. A single Mepilex Border dressing can cost several dollars at retail, while a box of gauze pads costs a fraction of that. Whether the higher per-unit cost is offset by fewer dressing changes, less nursing time, fewer complications, and faster healing depends on the wound and the setting. In hospital and long-term care environments, the economic case for advanced dressings tends to be more favorable because labor costs for dressing changes are high and complications like infections or pressure injuries are extremely expensive to treat. At home, the calculation is more personal and depends on how much the comfort and convenience advantages are worth to you.

Mepilex dressings are available by prescription in many healthcare systems and can also be purchased directly from medical supply retailers. Insurance coverage varies widely. In some countries, wound care dressings are covered under national health services or through specific wound care programs. In the United States, Medicare may cover advanced dressings for qualifying wound types when ordered by a physician, but navigating the paperwork can be cumbersome. It is worth asking your wound care provider about coverage before assuming you will need to pay out of pocket.